These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist.
    Author: Slifer BL, Dykstra LA.
    Journal: Life Sci; 1987 Jan 26; 40(4):343-9. PubMed ID: 3027481.
    Abstract:
    Rats were trained to discriminate ethylketocyclazocine (EKC) from vehicle, phencyclidine (PCP) from vehicle, or ethylketocyclazocine from phencyclidine on a two-lever operant task with a fixed-ratio 30 schedule of food-reinforcement on the appropriate lever. The three groups were tested with the training drugs (i.e., EKC and PCP), N-allylnormetazocine (NANM), and the (+)- and (-)-isomers of N-allylnormetazocine. EKC produced EKC-appropriate responding in the EKC-vehicle group and in the EKC-PCP group; it produced vehicle-appropriate responding in the PCP-vehicle group. Similarly, PCP produced PCP-appropriate responding in the PCP-vehicle group and in the EKC-PCP group but vehicle-appropriate responding in the EKC-vehicle group. The (+)-isomer of NANM produced PCP-appropriate responding in both the PCP-VEH and EKC-PCP groups, whereas the (-)-isomer produced EKC appropriate responding in the EKC-VEH and EKC-PCP groups. The results of this study demonstrate that rats can be trained to discriminate a kappa-agonist from a PCP/sigma-agonist and can differentiate these discriminative stimulus properties of other test compounds. These results also indicate that the (-)-isomer of NANM has kappa-agonist discriminative stimulus properties, whereas PCP/sigma-like effects are produced by the (+)-isomer.
    [Abstract] [Full Text] [Related] [New Search]